DOSSIER · 13F-HR · Q1 2026

ADAR1 Capital Management, LLC

$1.7B in tracked AUM across 311 positions as of Q1 2026.

AC
CIK 0001940272 · last filed Mar 31, 2026
Total AUM
$1.7B
as of Q1 2026
Holdings
311
positions
Whale Score
54
54
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

ADAR1 Capital Management, LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
ABVX
ABIVAX SA
$160M1.4M9.4%
02
PTGX
PROTAGONIST THERAPEUTICS INC
$105M994K6.2%
03
G76279101
ROIVANT SCIENCES LTD
$91M3.3M5.4%
04
IMVT
IMMUNOVANT INC
$67M2.7M3.9%
05
TERN
TERNS PHARMACEUTICALS INC
$59M1.1M3.5%
06
SPY
STATE STR SPDR S&P 500 ETF T
$49M76K2.9%
07
CYTK
CYTOKINETICS INC
$42M633K2.5%
08
CRNX
CRINETICS PHARMACEUTICALS IN
$41M1.1M2.4%
09
BOXX
EA SERIES TRUST
$39M337K2.3%
10
DNLI
DENALI THERAPEUTICS INC
$36M1.9M2.1%

Filing history

2026Q1Mar 31
$1.7B 24.8%
311 positionsView →
2025Q4Dec 31
$1.4B 76.4%
270 positionsView →
2025Q3Sep 30
$772M 18.3%
163 positionsView →
2025Q2Jun 30
$652M 67.1%
210 positionsLocked
2025Q1Mar 31
$390M 22.0%
147 positionsLocked
2024Q4Dec 31
$500M 18.6%
214 positionsLocked
2024Q3Sep 30
$615M 16.1%
278 positionsLocked
2024Q2Jun 30
$530M 20.2%
266 positionsLocked
2024Q1Mar 31
$441M 57.5%
261 positionsLocked
2023Q4Dec 31
$280M
170 positionsLocked